337 related articles for article (PubMed ID: 38391949)
21. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
22. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
24. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme.
Ye Z; Zhang T; He W; Jin H; Liu C; Yang Z; Ren J
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12341-12350. PubMed ID: 29564886
[TBL] [Abstract][Full Text] [Related]
26. Physical and Molecular Landscapes of Mouse Glioma Extracellular Vesicles Define Heterogeneity.
Gyuris A; Navarrete-Perea J; Jo A; Cristea S; Zhou S; Fraser K; Wei Z; Krichevsky AM; Weissleder R; Lee H; Gygi SP; Charest A
Cell Rep; 2019 Jun; 27(13):3972-3987.e6. PubMed ID: 31242427
[TBL] [Abstract][Full Text] [Related]
27. Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response.
Panzarini E; Tacconi S; Carata E; Mariano S; Tata AM; Dini L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171763
[TBL] [Abstract][Full Text] [Related]
28. Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.
Su YK; Lin JW; Shih JW; Chuang HY; Fong IH; Yeh CT; Lin CM
Cells; 2020 Aug; 9(8):. PubMed ID: 32784466
[No Abstract] [Full Text] [Related]
29. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
Rackles E; Lopez PH; Falcon-Perez JM
Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
[TBL] [Abstract][Full Text] [Related]
30. Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients.
Cilibrasi C; Simon T; Vintu M; Tolias C; Samuels M; Mazarakis NK; Eravci M; Stewart N; Critchley G; Giamas G
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052804
[TBL] [Abstract][Full Text] [Related]
31. Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
Zhang M; Li R; Pollom EL; Amini A; Dandapani S; Li G
J Clin Neurosci; 2020 Dec; 82(Pt A):122-127. PubMed ID: 33317719
[TBL] [Abstract][Full Text] [Related]
32. Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery.
Ghosh S; Huda P; Fletcher NL; Howard CB; Walsh B; Campbell D; Pinkham MB; Thurecht KJ
Mol Pharm; 2022 May; 19(5):1233-1247. PubMed ID: 35438509
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicle interplay in cardiovascular pathophysiology.
Saheera S; Jani VP; Witwer KW; Kutty S
Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1749-H1761. PubMed ID: 33666501
[TBL] [Abstract][Full Text] [Related]
34. CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy.
Jennrich S; Pelzer M; Tertel T; Koska B; Vüllings M; Thakur BK; Jendrossek V; Timmermann B; Giebel B; Rudner J
Front Oncol; 2022; 12():947439. PubMed ID: 36203458
[TBL] [Abstract][Full Text] [Related]
35. Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy.
Wang J; Liu Y; Liu F; Gan S; Roy S; Hasan I; Zhang B; Guo B
Nanoscale; 2023 Jul; 15(26):10904-10938. PubMed ID: 37337814
[TBL] [Abstract][Full Text] [Related]
36. Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients.
Maas SLN; van Solinge TS; Schnoor R; Yekula A; Senders JT; de Vrij J; Robe P; Carter BS; Balaj L; Arkesteijn GJA; Nolte-'t Hoen ENM; Broekman MLD
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33171819
[No Abstract] [Full Text] [Related]
37. Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment.
Xia Q; Liu L; Li Y; Zhang P; Han D; Dong L
Cancer Invest; 2021 Sep; 39(8):627-644. PubMed ID: 34254870
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.
Osti D; Del Bene M; Rappa G; Santos M; Matafora V; Richichi C; Faletti S; Beznoussenko GV; Mironov A; Bachi A; Fornasari L; Bongetta D; Gaetani P; DiMeco F; Lorico A; Pelicci G
Clin Cancer Res; 2019 Jan; 25(1):266-276. PubMed ID: 30287549
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy: A meta-analysis.
Wang WL; Aru N; Liu Z; Shen X; Ding YM; Wu SJ; Qin HH; Jin WY
Medicine (Baltimore); 2019 Nov; 98(45):e17759. PubMed ID: 31702627
[TBL] [Abstract][Full Text] [Related]
40. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
